These results show that these autoantibodies do not inhibit, but rather stimulate, GnRHR activity, which may lead to a possible increase in the pulsatile secretion of GnRH and disturbances in hormonal regulation characteristic of PCOS [13]. This evidence concerns the gene GNRH1 and polycystic ovary syndrome.